Projects per year
Personal profile
Personal profile
Dr. Butler graduated from Georgetown University School of Medicine in Washington, D.C. in 1982. He started his residency at Wilford Hall USAF Medical Center in San Antonio, Texas in 1982 and then completed his residency as Chief Resident at Stanford University Medical Center in 1986. After completing his postdoctoral training in 1987, Dr. Butler returned to the Wilford Hall USAF Medical Center where he became both the Chief of Radiation Oncology and the Chief of Brachytherapy. He also joined the faculty at The University of Texas Health Science Center at San Antonio as a Clinical Assistant Professor that same year. Dr. Butler would later join the Baylor College of Medicine where he would eventually become a full professor and the Chief of Radiation Oncology for both the medical school and the VA Hospital. He became the Medical Director of Radiation Oncology at Methodist in 1991, and received his faculty appointment at the Weill Medical School in 2006. He became Chair of Radiation Oncology at Houston Methodist in 2008. In 2016, Dr. Butler was named the Jim and Joan Harrell Chair in Radiation Oncology.
Research interests
Dr. Butler’s research centers on preclinical and clinical studies that combine radiation therapy and gene therapy for the treatment of prostate cancer. In recent years, he has extended these successful studies to other cancers, notably pancreatic cancer. His research interests also include three-dimensional reconstruction of body organs to assist in better localization of radiation therapy.
Education/Academic qualification
Radiation Therapy, Residency, Stanford School of Medicine
Jul 1 1984 → Jun 30 1987
Award Date: Jun 30 1987
MD, Georgetown University
… → May 31 1982
Award Date: May 31 1982
Research Area Keywords
- Imaging & Radiology
- Cancer
- Clinical Care
Free-text keywords
- Prostate cancer
- Pancreatic cancer
- Radiation therapy
- Gene therapy
- Computer visualization techniques
Fingerprint
- 20 Similar Profiles
Network
Projects
-
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer (NRG-GY020)
Farach, A. M., Alaniz, A., Butler, E. B., Darcourt, J., Haque, W. M., Morgan, P. B., Shadle, K. M., Shkedy, C., Singh, M., Suri, A. & Zaid, T.
6/22/20 → …
Project: Clinical Trial
-
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer (NRG-GY006)
Zaid, T., Butler, E. B., Darcourt, J., Farach, A. M., Kamat, A. A., Morgan, P. B., Shkedy, C., Singh, M. & Suri, A.
2/22/19 → …
Project: Clinical Trial
-
Phase II Window of Opportunity Trial of Stereotactic Body Radiation Therapy and In Situ Oncolytic Virus Therapy in Metastatic Triple Negative Breast Cancer and Metastatic Non-Small Cell Lung Cancer Followed by Pembrolizumab
Chang, J. C., Bernicker, E. H., Butler, E. B., Chan, E. Y., Darcourt, J., Farach, A. M., Gupta, N., Heyne, K., Kopas, L., Niravath, P. A., Singh, M., Sultenfuss, M. A., Teh, B. S. & Zhang, J.
5/23/17 → …
Project: Clinical Trial
-
A Randomized Phase III Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post-Lumpectomy Regional Nodal XRT in Patients With Positive Axillary Nodes Before Neoadjuvant Chemotherapy Who Convert to Pathologically Negative
Niravath, P. A., Bernicker, E. H., Butler, E. B., Chang, J. C., Darcourt, J., Farach, A. M., Haque, W. M., Heyne, K., Morgan, P. B., Shkedy, C. & Teh, B. S.
1/11/17 → …
Project: Clinical Trial
-
GOG0274The OUTBACK Trial
Kamat, A. A., Alaniz, A., Butler, E. B., Darcourt, J., Farach, A. M., Morgan, P. B., Shkedy, C., Singh, M., Suri, A. & Zaid, T.
2/3/15 → …
Project: Clinical Trial
Research Output
-
Approach to radiation therapy in the Jehovah's Witness patient: An overview
Jurica, J. M., Messer, J. A., Teh, B. S., Butler, E. B. & Farach, A. M., Nov 1 2020, In : Reports of Practical Oncology and Radiotherapy. 25, 6, p. 856-859 4 p.Research output: Contribution to journal › Review article
-
Clinical presentation, national practice patterns, and outcomes of breast adenomyoepithelioma
Haque, W. M., Verma, V., Suzanne Klimberg, V., Nangia, J., Schwartz, M., Butler, E. B. & Teh, B. S., Apr 1 2020, In : Breast Journal. 26, 4, p. 653-660 8 p.Research output: Contribution to journal › Article
-
Comparison of outcomes between metaplastic and triple-negative breast cancer patients
Polamraju, P., Haque, W., Cao, K., Verma, V., Schwartz, M., Klimberg, V. S., Hatch, S., Niravath, P., Butler, E. B. & Teh, B. S., Feb 2020, In : Breast. 49, p. 8-16 9 p.Research output: Contribution to journal › Article
2 Scopus citations -
Controversies in the Management of Solid Tumor Bone Metastases
Farach, A. M., Butler, E. B. & Teh, B. S., 2020, Medical Radiology. Springer, p. 241-253 13 p. (Medical Radiology).Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
Eye plaque brachytherapy versus enucleation for ocular melanoma: an analysis from the National Cancer Database
Messer, J. A., Zuhour, R. J., Haque, W., Lewis, G. D., Schefler, A. C., Wong, A., Bernicker, E. H., Chevez-Barrios, P., Michelle Quan, E., Farach, A., Butler, E. B., Hatch, S. S. & Teh, B. S., Aug 2020, In : Journal of Contemporary Brachytherapy. 12, 4, p. 303-310 8 p.Research output: Contribution to journal › Article